Targeted Oncology provides news, videos, and reviews on the rapidly evolving world of targeted therapies and immunotherapy ...

Researchers sought to determine whether combination therapy with zanubrutinib, obinutuzumab, and venetoclax would be effective for TP53-mutant MCL.

A new screening method to tackle bacterial resistance in a type of antibiotics has been developed by researchers at Oxford University.

Thirty-five fixed-dose combinations prohibited due to non-compliance with safety standards * Public safety threatened by drug ...

An evaluation of nearly 19,000 patients with metastatic colorectal cancer supported clinical trial data that immunotherapy ...

FDA approves the first treatment for KRAS-mutated recurrent low-grade serous ovarian cancer (LGSOC), offering new hope for ...

Discover the essential facts about chancroid, a lesser-known but serious STI that causes painful genital ulcers and increases ...

HealthDay News — A quality improvement program can improve recommended antibiotic duration in children for both acute otitis media (AOM) and community-acquired pneumonia (CAP) across multiple care ...

A TEENAGE boy developed a life-threatening heart infection just days after undergoing trendy cupping therapy. The otherwise healthy 17-year-old went to hospital with a high fever, chest pain, and ...

Researchers show how mice fed a Western-style diet are not able to rebuild a 'healthy,' diverse gut microbiome following antibiotic treatment. These mice were also more susceptible to infection by ...

Bacterial resistance negates the effect of antibiotics in the treatment of infection. Using mouse models, researchers now show that if antibiotics are administered with an enzyme called endolysin, the ...